Lidorestat

Overview

Lidorestat (IDD-676) is a potent, selective and orally active aldose reductase inhibitor with an IC 50 of 5 nM. Lidorestat can be used for chronic diabetes complications. Lidorestat also improves nerve conduction and reduces cataract formation.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Aldose Reductase

Product Information

• Catalog No.: HY-106198
• CAS No.: 245116-90-9
• Molecular Formula: C18H11F3N2O2S
• Molecular Weight: 376.35
• Purity: 99.50%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (5.53 mM); Clear solution
• Availability: In-stock

Source

Original product source